Furthermore, we also evaluated the molecular factors utilized by these antioxidants to control AAA in Ang II-induced as well as antioxidant-treated Apoe−/− mice, and the specific receptors employed by α-tocopherol and β-carotene to control AAA disease progression. This evidence concerns the gene AGT and triple-A syndrome.